GLP-1 Market
LLY $1431.67 ▼ -0.8% NVO $41.60 ▼ -0.1% PFE $28.86 ▼ -0.1% VKTX $26.80 ▼ -8.3% KLRA $12.57 ▼ -5.3% GPCR $18.57 ▼ -7.2% RHHBY $60.95 ▲ +1.1%
Market data delayed up to 20 min · Source: Twelve Data
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Ferric Derisomaltose

Company
Pharmacosmos A/S
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
20 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

20 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Nov 17, 2026

Find a Clinical Trial Near Me

See recruiting studies for Ferric Derisomaltose and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT04913649

    Intravenous Iron to Treat Postoperative Anemia in Older Cardiac Surgery Patients

    Not yet reported dr. P. Noordzij 310 participants Est. completion 2026-12 2 sites Stand-alone
    Other conditions: Iron Deficiency Anemia
    View official trial listing →
  • Recruiting NCT NCT05179226

    Multi-center Trial of Ferric Derisomaltose in Children 0 to <18 Years of Age With Iron Deficiency Anemia

    Not yet reported Pharmacosmos A/S 200 participants Est. completion 2027-04-30 1 site Stand-alone
    Other conditions: Iron Deficiency, Anaemia in Children
    View official trial listing →
  • Recruiting NCT NCT05251493

    Ferric Derisomaltose (Iron Isomaltoside) Versus Iron Sucrose for Treatment of Iron Deficiency in Pregnancy

    Not yet reported Saskatchewan Health Authority - Regina Area 280 participants Est. completion 2027-02-28 1 site
    Other conditions: Iron Deficiency Anaemia in Childbirth
    View official trial listing →
  • Recruiting NCT NCT05304442

    IV Iron Trial for Anemia Related to Uterine Bleeding in Female Patients Presenting to the Emergency Department

    Not yet reported Baylor College of Medicine 40 participants Est. completion 2025-04 1 site Stand-alone
    Other conditions: Anemia, Iron Deficiency, Uterine Bleeding
    View official trial listing →
  • Recruiting NCT NCT05407987

    Ferric Derisomaltose and Outcomes in the Recovery of Gynecologic Oncology: ERAS (Enhanced Recovery After Surgery)

    Not yet reported AHS Cancer Control Alberta 82 participants Est. completion 2027-12-30 1 site Stand-alone
    Other conditions: Gynecologic Cancer, Anemia, Iron-deficiency
    View official trial listing →
  • Recruiting NCT NCT05462704

    Intravenous Versus Oral Iron for Treating Iron-Deficiency Anemia in Pregnancy

    Not yet reported Women and Infants Hospital of Rhode Island 300 participants Est. completion 2027-03-31 8 sites Stand-alone
    Other conditions: Iron Deficiency Anemia, Pregnancy
    View official trial listing →
  • Recruiting NCT NCT05714007

    The Effects of Ferric Derisomaltose on Postoperative Anemia in Spinal Deformity Surgery

    Not yet reported Peking Union Medical College Hospital 120 participants Est. completion 2025-12 1 site Stand-alone
    Other conditions: Perioperative Anemia, Surgery, Spinal Deformity, Adult
    View official trial listing →
  • Recruiting NCT NCT05763043

    Monoferric for Prenatal Iron Deficiency

    Not yet reported Oregon Health and Science University 80 participants Est. completion 2028-10 1 site Stand-alone
    Other conditions: Obstetric Labor Complications
    View official trial listing →
  • Recruiting NCT NCT05929729

    Iron Deficiency Anemia (IDA) and the Brain

    Not yet reported Children's Hospital Los Angeles 120 participants Est. completion 2028-09-01 4 sites Stand-alone
    Other conditions: IDA - Iron Deficiency Anemia, Anemia, Iron Deficiency Anemia, Anemia, Iron Deficiency
    View official trial listing →
  • Recruiting NCT NCT05971732

    The Effects of Ferric Derisomaltose in Patients With Acute Heart Failure and Iron Deficiency on Exercise Capacity and Quality of Life(COREVIVE-HFrEF)

    Not yet reported China-Japan Friendship Hospital 146 participants Est. completion 2027-08-01 1 site Stand-alone
    Heart failure Other conditions: Iron Deficiency
    View official trial listing →
  • Recruiting NCT NCT05991128

    The Effects of Ferric Derisomaltose in Patients With Acute Heart Failure and Iron Deficiency on Exercise Capacity and Quality of Life

    Not yet reported China-Japan Friendship Hospital 170 participants Est. completion 2027-08-01 1 site Stand-alone
    Heart failure Other conditions: Iron Deficiencies
    View official trial listing →
  • Recruiting NCT NCT06287619

    Post-operative Intravenous Iron to Treat Iron-deficiency Anemia in Patients Undergoing Cardiac Surgery

    Not yet reported University Health Network, Toronto 60 participants Est. completion 2027-06 3 sites Stand-alone
    Other conditions: Chronic Iron Deficiency Anaemia, Cardiac Surgery
    View official trial listing →
  • Recruiting NCT NCT06427343

    The Effects of Low-Dose Versus High-Dose Intravenous IRON Therapy With Ferric DerisomaltOSE in Patients With Chronic Heart Failure and Iron Deficiency

    Not yet reported China-Japan Friendship Hospital 114 participants Est. completion 2027-08-01 1 site Stand-alone
    Heart failure Other conditions: Iron Deficiency
    View official trial listing →
  • Recruiting NCT NCT06542822

    IRONHEART: Intravenous Iron in Non-ischaemic Heart Failure

    University Hospital Southampton NHS Foundation Trust 16 participants Est. completion 2027-02 1 site
    Heart failure Other conditions: Iron Deficiencies
    View official trial listing →
  • Recruiting NCT NCT06670963

    Use of Epoetin Alfa and Iron Derisomaltose in Treatment of Anemia in Patients With Sepsis or Septic Shock: a Randomized Controlled Trial

    Not yet reported Piotr Czempik 200 participants Est. completion 2027-04-01 1 site Stand-alone
    Other conditions: Anemia, Sepsis, Septic Shock
    View official trial listing →
  • Recruiting NCT NCT06884280

    Comparing High and Low Dose Iron Treatments for People on Peritoneal Dialysis: The PALaDIN Study

    Not yet reported Hull University Teaching Hospitals NHS Trust 30 participants Est. completion 2027-10 1 site Stand-alone
    Other conditions: Peritoneal Dialysis, Anaemia, Iron Deficiency, Anaemia
    View official trial listing →
  • Recruiting NCT NCT06898814

    The Effects of Intravenous Iron on Mobility in Elderly Patients Following Hip Fracture Surgery

    Not yet reported Soren Overgaard 210 participants Est. completion 2027-09-14 3 sites
    Other conditions: Hip Fracture, Anemia
    View official trial listing →
  • Recruiting NCT NCT06929806

    Multi-center Trial of Ferric Derisomaltose Versus no Intravenous Iron in Iron-deficient Subjects With Symptomatic Chronic Heart Failure

    Not yet reported Pharmacosmos A/S 1900 participants Est. completion 2027-12-01 1 site Stand-alone
    Heart failure Other conditions: Iron Deficiencies
    View official trial listing →
  • Recruiting NCT NCT07236788

    Study on Supplement of Intravenous Ferric Derisomaltose to Prevent Anemia and Improve the Quality of Life in Obese Patients With Iron Deficiency.

    Not yet reported China-Japan Friendship Hospital 200 participants Est. completion 2027-03-30 1 site
    Other conditions: Obesity, Anemia, Iron Deficiencies, Bariatric Surgery
    View official trial listing →
  • Recruiting NCT NCT07790562

    A Study of Ferric Derisomaltose Injection in Chinese Participants With Iron Deficiency Anemia Under Fasting Conditions

    Not yet reported Sichuan Huiyu Pharmaceutical Co., Ltd 88 participants Est. completion 2026-11-01 1 site Stand-alone
    Other conditions: Iron Deficiency Anemia
    View official trial listing →
  • Completed NCT NCT00536666

    A Study of Iron Oligosaccharide in Chronic Kidney Disease Patients

    Not yet reported Pharmacosmos A/S 182 participants Est. completion 2008-08 1 site
    Chronic kidney disease Other conditions: Anemia, Iron-Deficiency
    View official trial listing →
  • Completed NCT NCT00537186

    A Study of Iron Oligosaccharide in CHF Patients

    Not yet reported Pharmacosmos A/S 20 participants Est. completion 2008-07 1 site
    Heart failure
    View official trial listing →
  • Completed NCT NCT01017614

    Iron Oligosaccharide in Inflammatory Bowel Disease Subjects With Iron Deficiency Anaemia

    Not yet reported Pharmacosmos A/S 350 participants Est. completion 2012-08 10 sites Stand-alone
    Other conditions: Inflammatory Bowel Disease
    View official trial listing →
  • Completed NCT NCT01102413

    Iron Isomaltoside 1000 (Monofer®) in Non-Dialysis Dependent Chronic Kidney Disease and With Renal-Related Anaemia

    Not yet reported Pharmacosmos A/S 351 participants Est. completion 2014-06 1 site Stand-alone
    Chronic kidney disease Other conditions: Iron Deficiency Anemia
    View official trial listing →
  • Completed NCT NCT01145638

    A Study of Intravenous Iron Isomaltoside 1000 (Monofer®) as Mono Therapy (Without Erythropoiesis Stimulating Agents) in Comparison With Oral Iron Sulfate in Subjects With Non-myeloid Malignancies Associated With Chemotherapy Induced Anaemia (CIA)

    Not yet reported Pharmacosmos A/S 350 participants Est. completion 2014-05 1 site
    Other conditions: Non-myeloid Malignancies, Chemotherapy Induced Anaemia
    View official trial listing →
  • Completed NCT NCT01213680

    Open-label PK Study of Iron Isomaltoside 1000 (Monofer) Administered by 500 mg IV Injection or 1000 mg IV Infusion to Patients With Inflammatory Bowel Disease

    Not yet reported Pharmacosmos A/S 16 participants Est. completion 2012-11
    Other conditions: Inflammatory Bowel Disease
    View official trial listing →
  • Completed NCT NCT01213979

    Open-label Pharmacokinetic Study of Iron Isomaltoside 1000 (Monofer®) Administered by 500 mg IV Bolus Injection or 1000 mg Intravenous Infusion to Patients With Non-hematological Malignancies Associated With Chemotherapy Induced Anaemia (CIA)

    Not yet reported Pharmacosmos A/S 16 participants Est. completion 2012-07
    Other conditions: Non-hematological Malignancies
    View official trial listing →
  • Completed NCT NCT01213992

    Open-label Pharmacokinetic Study of Iron Isomaltoside 1000 (Monofer®) Administered by 500 mg IV Bolus Injection or 1000 mg Intravenous to Patients With CKD

    Not yet reported Pharmacosmos A/S 16 participants Est. completion 2012-11
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT01222884

    A Randomized, Comparative, Open-label Study of IV Monofer® Administered as Maintenance Therapy by Single or Repeated Bolus Injections in Comparison With IV Iron Sucrose in Subjects With CKD-5D

    Not yet reported Pharmacosmos A/S 351 participants Est. completion 2013-12 1 site
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT01280240

    Pharmacokinetic Study of Iron Isomaltoside 1000 Administered by 250 mg IV Bolus Injection or 500 mg Intravenous Infusion to Patients With Non-hematological Malignancies Associated With Chemotherapy Induced Anaemia

    Not yet reported Pharmacosmos A/S 11 participants Est. completion 2012-11 2 sites
    Other conditions: Patients With Chemotherapy Induced Anemia (CIA)
    View official trial listing →
  • Completed NCT NCT01410435

    Safety and Efficacy Extension Study of Iron Isomaltoside 1000 (Monofer®) in Subjects With Inflammatory Bowel Disease

    Not yet reported Pharmacosmos A/S 39 participants Est. completion 2013-09 2 sites Stand-alone
    Other conditions: Inflammatory Bowel Disease, Anaemia
    View official trial listing →
  • Completed NCT NCT01469078

    Open-label Pharmacokinetic Study of Iron Isomaltoside 1000 (Monofer®) Administered as Single Bolus Injections in Subjects With Stage 5 Chronic Kidney Disease on Dialysis Therapy (CKD-5D)

    Not yet reported Pharmacosmos A/S 18 participants Est. completion 2012-11
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT01563367

    A Prospective, Comparative Study of Intravenous Iron Isomaltoside 1000 (Monofer®) Administered by Infusions to Non-Anaemic Patients Undergoing Elective or Sub-Acute Coronary Artery Bypass Graft, Valve Replacement or a Combination Thereof

    Not yet reported Pharmacosmos A/S 74 participants Est. completion 2013-09 1 site
    Other conditions: Non-anaemic Patients Undergoing Cardiac Surgery
    View official trial listing →
  • Completed NCT NCT01599702

    Iron Isomaltoside 1000 (Monofer®) Administered by a High Dosing Regimen in Subjects With Inflammatory Bowel Disease

    Not yet reported Pharmacosmos A/S 21 participants Est. completion 2014-12 1 site Stand-alone
    Other conditions: Inflammatory Bowel Disease
    View official trial listing →
  • Completed NCT NCT01628770

    Use of Iron Isomaltoside 1000 (Monofer) in Postpartum Anemia

    Not yet reported Dow University of Health Sciences 271 participants Est. completion 2012-12 1 site Stand-alone
    Other conditions: Postpartum Anemia
    View official trial listing →
  • Completed NCT NCT01895205

    Treatment of Women After Severe Postpartum Haemorrhage

    Not yet reported Pharmacosmos A/S 13 participants Est. completion 2015-08 1 site
    Other conditions: Severe Postpartum Haemorrhage
    View official trial listing →
  • Completed NCT NCT01895218

    Treatment of Women After Postpartum Haemorrhage

    Not yet reported Pharmacosmos A/S 200 participants Est. completion 2014-12 1 site Stand-alone
    Other conditions: Postpartum Haemorrhage
    View official trial listing →
  • Completed NCT NCT01895231

    A Study of Intravenous Iron Isomaltoside 1000 (Monofer®) Administered by Infusions to Iron-deficient Blood Donors

    Not yet reported Pharmacosmos A/S 107 participants Est. completion 2016-12 1 site Stand-alone
    Other conditions: Iron-deficiency
    View official trial listing →
  • Completed NCT NCT01900197

    Time to Relapse of Iron Deficiency Anemia After Standard Treatment With a New Intravenous Iron (Monofer®)

    Pharmacosmos A/S 391 participants Est. completion 2015-11 1 site
    Other conditions: Iron Deficiency Anemia
    View official trial listing →
  • Status unknown NCT NCT01927328

    Iron Replacement in Oesophagogastric Neoplasia

    Not yet reported Nottingham University Hospitals NHS Trust 40 participants Est. completion 2017-08 1 site
    Other conditions: Anemia, Esophageal Cancer, Gastric Cancer
    View official trial listing →
  • Completed NCT NCT02130063

    IDA-01 A Randomised, Open-Label, Comparative Study of Intravenous Iron Isomaltoside 1000 (Monofer®) and Iron Sucrose

    Not yet reported Pharmacosmos A/S 511 participants Est. completion 2015-08 1 site Stand-alone
    Other conditions: Iron Deficiency Anaemia
    View official trial listing →
  • Withdrawn NCT NCT02172001

    A Randomized, Double-blind, Comparative Study of Intravenous Iron Isomaltoside 1000 (Monofer®) Against Placebo

    Not yet reported Pharmacosmos A/S 1 site
    Other conditions: Iron Deficiency Anemia
    View official trial listing →
  • Status unknown NCT NCT02385383

    An Intravenous Iron Based Protocol for Preoperative Anaemia in Hip and Knee Surgery - An Observational Study

    Copenhagen University Hospital, Rigshospitalet 300 participants Est. completion 2017-02 6 sites
    Other conditions: Anemia, Arthroplasty, Replacement, Hip, Arthroplasty, Replacement, Knee
    View official trial listing →
  • Withdrawn NCT NCT02484768

    IV Iron Treatment of Restless Legs Syndrome

    Not yet reported Pharmacosmos A/S Est. completion 2015-02
    Other conditions: Restless Legs Syndrome
    View official trial listing →
  • Completed NCT NCT02546154

    Time to Relapse of Iron Deficiency Anaemia After Standard Treatment With The Intravenous Iron (Monofer®)

    Pharmacosmos UK Ltd 359 participants Est. completion 2018-12 1 site
    Other conditions: Iron Deficiency Anaemia
    View official trial listing →
  • Completed NCT NCT02642562

    Intravenous Iron Treatment in Patients With Heart Failure and Iron Deficiency: IRONMAN

    Not yet reported University of Glasgow 1160 participants Est. completion 2022-08-26 72 sites Stand-alone
    Heart failure Other conditions: Iron Deficiency, Left Ventricular Systolic Dysfunction
    View official trial listing →
  • Completed NCT NCT02862665

    Effect of Perioperative Iron Isomaltoside 1000 Administration on Transfusion Requirements in Patients Undergoing Complex Valvular Heart Surgery: a Randomized Clinical Trial

    Not yet reported Yonsei University 214 participants Est. completion 2020-05-07 1 site Stand-alone
    Other conditions: Complex Valvular Heart Surgery
    View official trial listing →
  • Completed NCT NCT02905539

    A Study Comparing the Iron Substitution With the Medicinal Products Ferinject or Monofer

    Not yet reported Universität des Saarlandes 26 participants Est. completion 2020-06 1 site
    Other conditions: Anemia, Iron-Deficiency
    View official trial listing →
  • Completed NCT NCT02940860

    Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for Treatment of Iron Deficiency Anemia in Non-Dialysis-Dependent Chronic Kidney Disease

    Not yet reported Pharmacosmos A/S 1538 participants Est. completion 2018-05-29 141 sites Stand-alone
    Chronic kidney disease Other conditions: Iron Deficiency Anaemia, Iron Deficiency Anemia
    View official trial listing →
  • Completed NCT NCT02940886

    Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for the Treatment of Iron Deficiency Anemia (IDA)

    Not yet reported Pharmacosmos A/S 1512 participants Est. completion 2018-03-28 114 sites Stand-alone
    Other conditions: Iron Deficiency Anaemia, Iron Deficiency Anemia
    View official trial listing →
  • Completed NCT NCT02962648

    An Extension Trial to Assess the Safety of Re-dosing of Iron Isomaltoside/Ferric Derisomaltose (Monofer®/Monoferric®)

    Not yet reported Pharmacosmos A/S 103 participants Est. completion 2018-06-12 22 sites Stand-alone
    Other conditions: Iron Deficiency Anemia, Iron Deficiency Anaemia
    View official trial listing →
  • Terminated NCT NCT02972294

    HiFIT Study : Hip Fracture: Iron and Tranexamic Acid

    Not yet reported University Hospital, Angers 419 participants Est. completion 2021-09-16 13 sites
    Other conditions: Hip Fractures Pathologic, Anemia
    View official trial listing →
  • Status unknown NCT NCT02999217

    Intravenous Iron for Correction of Anaemia After Colorectal Surgery

    Not yet reported Kaunas University of Medicine 100 participants Est. completion 2018-10 1 site
    Other conditions: Anemia, Iron-Deficiency, Intravenous Drug Usage, Colorectal Neoplasms, Colorectal Surgery
    View official trial listing →
  • Completed NCT NCT03013439

    Dose-escalation Trial of the Safety, Pharmacokinetics, and Pharmacodynamics of Iron Isomaltoside (Monofer®)

    Not yet reported Pharmacosmos A/S 24 participants Est. completion 2017-06-04 1 site
    Other conditions: Anemia, Deficiency Diseases, Anemia, Iron Deficiency, Hematologic Disease, Iron Metabolism Disorders
    View official trial listing →
  • Status unknown NCT NCT03094182

    Efficacy of Intravenous Iron Therapy in Maintaining Hemoglobin Concentration on Patients Undergoing Bimaxillary Orthognathic Surgery

    Not yet reported Yonsei University 58 participants Est. completion 2019-08 1 site Stand-alone
    Other conditions: Facial Asymmetry, Retrognathism, Prognathism
    View official trial listing →
  • Completed NCT NCT03188445

    Intravenous Iron Isomaltoside Versus Oral Iron Supplementation for Treatment of Iron Deficiency in Pregnancy.

    Not yet reported Pharmacosmos A/S 201 participants Est. completion 2020-08-18 1 site Stand-alone
    Other conditions: Iron Deficiency Anemia of Pregnancy
    View official trial listing →
  • Status unknown NCT NCT03229954

    Intravenous Iron Isomaltoside 1000 (Monofer®) Compared With Oral Iron in the Treatment of Postgastrectomy Anemia: An Open-label Randomized Controlled Trial

    Not yet reported Yonsei University 358 participants Est. completion 2019-04 1 site Stand-alone
    Other conditions: Post Gastrectomy Anemia
    View official trial listing →
  • Completed NCT NCT03237065

    Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose or Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia

    Not yet reported Pharmacosmos A/S 122 participants Est. completion 2018-05-29 15 sites Stand-alone
    Other conditions: Iron Deficiency Anaemia, Iron Deficiency Anemia
    View official trial listing →
  • Completed NCT NCT03238911

    Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose vs Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia

    Not yet reported Pharmacosmos A/S 123 participants Est. completion 2018-06-19 16 sites Stand-alone
    Other conditions: Iron Deficiency Anaemia, Iron Deficiency Anemia
    View official trial listing →
  • Completed NCT NCT03346213

    CArdio PulmOnary Exercise Testing and IntRAvenous Iron- 'CAPOEIRA-I STUDY'

    University Hospital Southampton NHS Foundation Trust 26 participants Est. completion 2018-10-01 1 site
    Other conditions: Anemia, Anemia, Iron Deficiency
    View official trial listing →
  • Completed NCT NCT03466983

    A Trial Comparing the Incidence of Hypophosphatemia in Relation to Treatment With Iron Isomaltoside and Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia Due to Inflammatory Bowel Disease

    Not yet reported Pharmacosmos A/S 97 participants Est. completion 2020-05-25 1 site Stand-alone
    Other conditions: IBD
    View official trial listing →
  • Completed NCT NCT03470649

    Effect of IV Iron Isomaltoside on Postoperative Anemia in Total Knee Arthroplasty Patients

    Not yet reported Seoul National University Hospital 100 participants Est. completion 2019-04-17 1 site Stand-alone
    Other conditions: Anemia, Knee Arthropathy
    View official trial listing →
  • Completed NCT NCT03565354

    Efficacy of Preoperative Intravenous Iron in Anaemic Colorectal Cancer Surgical Patients

    Not yet reported Prince of Wales Hospital, Shatin, Hong Kong 40 participants Est. completion 2020-06-30 1 site
    Other conditions: Anemia, Iron-Deficiency, Colorectal Cancer
    View official trial listing →
  • Terminated NCT NCT03610230

    Iron Isomaltoside Compared With Iron Sucrosein Peritoneal Dialysis Patients

    Not yet reported The University of Hong Kong 16 participants Est. completion 2021-03-30 1 site Stand-alone
    Other conditions: Iron Deficiency Anemia Treatment
    View official trial listing →
  • Completed NCT NCT03662789

    Intravenous Iron Supplement for Iron Deficiency in Cardiac Transplant Recipients

    Not yet reported, Not yet reported Oslo University Hospital 102 participants Est. completion 2020-02-27 1 site
    Other conditions: Heart Transplant Recipients
    View official trial listing →
  • Status unknown NCT NCT03888768

    ProPBM : A Modified Patient Blood Management Protocol

    Not yet reported Ministry of Health, Malaysia 180 participants Est. completion 2021-12 1 site
    Other conditions: Iron-deficiency
    View official trial listing →
  • Completed NCT NCT03957057

    Intravenous Iron Carboxymaltose, Isomaltoside and Oral Iron Sulphate for Postpartum Anemia

    Not yet reported University Medical Centre Ljubljana 300 participants Est. completion 2022-06-15 1 site Stand-alone
    Other conditions: Postpartum Anemia Nos, Iron-deficiency
    View official trial listing →
  • Completed NCT NCT04206228

    Intravenous Iron Supplement for Iron Deficiency in Patients With Severe Aortic Stenosis

    Not yet reported Oslo University Hospital 149 participants Est. completion 2022-02-15 1 site
    Other conditions: Severe Aortic Stenosis, Iron-deficiency
    View official trial listing →
  • Completed NCT NCT04608539

    A Clinical Trial Assessing the Efficacy of Intravenous Iron for the Treatment of Anemia Following Cardiac Surgery

    Not yet reported Michael Kremke 110 participants Est. completion 2023-06-27 1 site Stand-alone
    Other conditions: Anemia Postoperative
    View official trial listing →
  • Status unknown NCT NCT04642521

    Association Between Anaemia and Handgrip Strength in Female Planned for Major Surgery and the Effect of Intravenous Iron on Handgrip Strength

    University of Malaya 65 participants Est. completion 2021-04-30 1 site
    Other conditions: Anemia, Iron-deficiency, Patient Blood Management, Iron Deficiency Anemia
    View official trial listing →
  • Completed NCT NCT04945707

    Impact of Intravenous Iron Repletion On Mechanisms of Exercise InTolerance in HFpEF (IRONMET-HFpEF)

    Not yet reported, Not yet reported Massachusetts General Hospital 65 participants Est. completion 2026-08-01 1 site
    Heart failure Other conditions: Iron-deficiency
    View official trial listing →
  • Not yet recruiting NCT NCT05220800

    Effects of Intravenous Administered Iron in Non-anemic Iron Deficient Patients With Colorectal Cancer

    Not yet reported Zealand University Hospital 134 participants Est. completion 2029-03-01 3 sites
    Other conditions: Iron-deficiency, Colorectal Cancer
    View official trial listing →
  • Status unknown NCT NCT05221957

    Effects of Preoperative Correction of Anemia With Intravenously Iron in Colorectal Cancer Patients.

    Not yet reported Zealand University Hospital 200 participants Est. completion 2023-12
    Other conditions: Colorectal Cancer, Anemia, Iron-deficiency
    View official trial listing →
  • Completed NCT NCT05258825

    Preoperative Monoferric for Abdominal Surgery

    Not yet reported Brigham and Women's Hospital 37 participants Est. completion 2025-06-25 1 site Stand-alone
    Other conditions: Anemia, Surgery
    View official trial listing →
  • Completed NCT NCT05358509

    Reducing Anemia in Pregnancy in India: the RAPIDIRON Trial

    Not yet reported Thomas Jefferson University 4368 participants Est. completion 2024-01-21 4 sites
    Other conditions: Iron Deficiency Anemia, Infant, Low Birth Weight, Anemia of Pregnancy
    View official trial listing →
  • Status unknown NCT NCT05467319

    Ferric Derisomaltose/Iron Isomaltoside and Outcomes in the Recovery of Gynecologic Oncology ERAS

    Not yet reported Alberta Health Services, Calgary 82 participants Est. completion 2023-12 Stand-alone
    Other conditions: Gynecologic Cancer, Anemia, Iron Deficiency, Surgery
    View official trial listing →
  • Status unknown NCT NCT05504863

    RAPIDIRON Trial Follow-up Study: RAPIDIRON-KIDS Study

    Thomas Jefferson University 538 participants Est. completion 2026-01 3 sites
    Other conditions: Iron Deficiency Anemia, Neurodevelopmental Abnormality, Autism Spectrum Disorder
    View official trial listing →
  • Completed NCT NCT05545527

    Neuroimaging Ancillary Study

    Thomas Jefferson University 184 participants Est. completion 2025-04-07 1 site
    Other conditions: Iron Deficiency Anemia, Iron Deficiency Anemia of Pregnancy, Neurodevelopmental Disorder of Foetus, Iron Deficiency Anemia Treatment, Fetal Neurodevelopmental Disorder, Child Development
    View official trial listing →
  • Status unknown NCT NCT05581420

    Oral Versus Intravenous Iron in IBD Patients With Anti-inflammatory Therapy.

    Not yet reported Leiden University Medical Center 152 participants Est. completion 2025-05 1 site
    Other conditions: Inflammatory Bowel Diseases
    View official trial listing →
  • Status unknown NCT NCT05719376

    The Effect of Intravenous Iron Therapy and Erythropoiesis-stimulation Agent Combination on Renal Transplant Outcomes

    Not yet reported Yonsei University 302 participants Est. completion 2026-06 1 site Stand-alone
    Other conditions: Kidney Failure, Chronic
    View official trial listing →
  • Status unknown NCT NCT05768997

    High Dose IV Iron Plus ESA in Chemotherapy-induced Anemia

    Not yet reported Hallym University Medical Center 312 participants Est. completion 2025-12-31 1 site Stand-alone
    Other conditions: Anemia
    View official trial listing →
  • Status unknown NCT NCT05804071

    Analysis of the Effect of Iron Supplements on Iron Deficiency Anemia in Pregnancy

    Not yet reported Qianfoshan Hospital 452 participants Est. completion 2025-01 1 site
    Other conditions: Iron Deficiency Anemia of Pregnancy, Iron Storage Disease
    View official trial listing →
  • Status unknown NCT NCT05911438

    Accelerated Recovery for Total Knee Replacement Surgery With Preoperative Intravenous Iron Combined With Human Erythropoietin for Rapid Hematopoietic Mobilization to Prevent Postoperative Anemia

    Not yet reported West China Hospital 419 participants Est. completion 2025-06 1 site Stand-alone
    Other conditions: Total Knee Arthroplasty
    View official trial listing →
  • Not yet recruiting NCT NCT06248749

    Effect of Intravenously Iron Infusion on the Prevention and Treatment of Anemia in Ovarian Cancer

    Not yet reported University of Saskatchewan 200 participants Est. completion 2029-12-01 2 sites
    Other conditions: Anaemia in Ovarian Carcinoma
    View official trial listing →
  • Completed NCT NCT06309641

    Methemoglobinemia Following Intravenous Iron Treatment

    Claudia Seiler 50 participants Est. completion 2025-10-13 1 site
    Other conditions: Methemoglobinemia, Anemia, Iron Deficiencies, Side Effect
    View official trial listing →
  • Status unknown NCT NCT06350955

    IV Iron-induced Hypophosphatemia After RYGB

    Not yet reported Lucie Favre 94 participants Est. completion 2026-06 1 site
    Other conditions: Hypophosphatemia, Roux-en-Y Gastric Bypass
    View official trial listing →
  • Not yet recruiting NCT NCT07238972

    Postoperative Intravenous Ferric Derisomaltose for Prevention of Long-term Anemia After Cardiac Surgery

    Not yet reported Yonsei University 180 participants Est. completion 2030-10 1 site Stand-alone
    Other conditions: Anemia, Iron Deficiencies, Iron Deficiency Anemia, Cardiac Surgery, Heart Valve Diseases
    View official trial listing →
  • Not yet recruiting NCT NCT07314424

    The Effect of Preoperative Intravenous Ferric Derisomaltose and EPO and Tranexamic Acid in Patients With Preoperative Anemia or Iron Deficiency in Bone Tumor

    Not yet reported Tang Xiaodong 160 participants Est. completion 2027-10-01
    Other conditions: Anemia
    View official trial listing →
  • Enrolling by invitation NCT NCT07643818

    Intravenous Iron to Improve Symptoms, Quality of Life and Exercise Capacity in HFpEF With Iron Deficiency

    Not yet reported Government of Jersey 150 participants Est. completion 2029-12 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Not yet recruiting NCT NCT07659184

    IRONCARE: Iron Treatment in Older Patients With Hip Fractures

    Not yet reported University of Aarhus 528 participants Est. completion 2028-09-30 5 sites
    Other conditions: Hip Fracture, Anemia, Iron, Placebo - Control
    View official trial listing →
  • Not yet recruiting NCT NCT07686692

    IV Iron Therapy for Older Adults With Heart Failure With Preserved Ejection Fraction and Iron Deficiency

    Not yet reported Duke University 300 participants Est. completion 2030-08 1 site Stand-alone
    Heart failure Other conditions: Iron Deficiency
    View official trial listing →
  • Not yet recruiting NCT NCT07903311

    Iron Repletion in Cystic Fibrosis

    Not yet reported University of Michigan 100 participants Est. completion 2030-04 8 sites Stand-alone
    Other conditions: Cystic Fibrosis, Iron Deficiencies, Iron Deficiency Diseases
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Ferric Derisomaltose, Monoferric, Ferric Derisomaltose Injection, Monofer, Iron (III) isomaltoside 1000

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.